The term PBP Activators typically refers to a category of chemical entities that interact with Penicillin-Binding Proteins (PBPs) to modulate their enzymatic activity. These activators are distinct from classical antibacterial agents which inhibit PBP activity; instead, they bind to PBPs in a manner that can potentially enhance their natural role in bacterial cell wall biosynthesis. The concept of PBP activation is rooted in the intricate process of peptidoglycan layer formation, a critical aspect of bacterial cell wall structuring that maintains cell shape and protects against osmotic pressure. PBPs are key enzymes in this process, catalyzing the cross-linking of peptidoglycan strands, and their function is essential for the growth and survival of bacteria.
Activators of PBPs are studied for their unique interaction with the active sites of these proteins. They may function by binding to allosteric sites, changing the conformation of the enzyme in a way that increases its affinity for natural substrates or enhances the catalytic rate of peptidoglycan synthesis. These compounds may also act by stabilizing the PBP in a particular conformation that is more efficient for its enzymatic function. The structure of PBP activators can vary significantly, with each activator having a unique configuration that determines its specific interaction with the PBP enzyme. The study of such activators involves understanding the biochemistry of the PBP active site and the dynamic process by which peptidoglycan strands are cross-linked. The interactions between PBP activators and their target enzymes are complex and can be influenced by the precise chemical structure of the activator, the type of PBP, and the local environment within the bacterial cell wall. Research in this field aims to elucidate the mechanistic details of how PBP activators influence the enzymatic activity of PBPs and to understand the biochemical consequences of these interactions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ampicillin | 69-53-4 | sc-210812 sc-210812A sc-210812B sc-210812C sc-210812D | 100 mg 1 g 5 g 25 g 100 g | $31.00 $101.00 $153.00 $115.00 $408.00 | 11 | |
Ampicillin is a beta-lactam antibiotic that can bind to PBPs, potentially inducing a bacterial response that upregulates PBP expression to compensate for inhibited cell wall synthesis. | ||||||
Cefotaxime | 63527-52-6 | sc-353131 sc-353131A | 1 g 5 g | $292.00 $938.00 | 1 | |
Cefotaxime, another beta-lactam antibiotic, could lead to the induction of PBP expression as a bacterial countermeasure to restore cell wall integrity. | ||||||
Bacitracin | 1405-87-4 | sc-252399 | 5 g | $89.00 | 1 | |
Bacitracin interferes with peptidoglycan synthesis, and bacteria may upregulate PBP expression in an attempt to counteract this effect. | ||||||
Fosfomycin Calcium | 26016-98-8 | sc-204760 sc-204760A | 5 g 25 g | $233.00 $490.00 | 1 | |
Fosfomycin inhibits an early step in peptidoglycan synthesis. Bacteria might respond by altering PBP expression as a compensatory mechanism. | ||||||
Isoniazid | 54-85-3 | sc-205722 sc-205722A sc-205722B | 5 g 50 g 100 g | $26.00 $101.00 $146.00 | ||
Isoniazid targets mycolic acid synthesis in mycobacteria. Though not directly related to PBPs, stress responses to such agents could theoretically affect PBP levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, which could lead to a complex stress response and potentially affect the expression of a variety of proteins, including PBPs. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline inhibits protein synthesis and could indirectly cause bacteria to alter PBP expression in an attempt to deal with the effects of inhibited protein synthesis. | ||||||
D-Cycloserine | 68-41-7 | sc-221470 sc-221470A sc-221470B sc-221470C | 200 mg 1 g 5 g 25 g | $28.00 $77.00 $142.00 $530.00 | 4 | |
D-cycloserine inhibits cell wall synthesis in bacteria, which could lead to a compensatory increase in PBP expression to try to maintain cell wall integrity. | ||||||
Nitrofurantoin | 67-20-9 | sc-212399 | 10 g | $84.00 | ||
Nitrofurantoin damages bacterial DNA and ribosomal proteins, potentially leading to a stress response that could include changes in PBP expression. | ||||||